Serum soluble mediators as prognostic biomarkers for morbidity, disease outcome, and late-relapsing hepatitis in yellow fever patients

Copyright © 2023. Published by Elsevier Inc.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 251(2023) vom: 01. Juni, Seite 109321
1. Verfasser: Fradico, Jordana Rodrigues Barbosa (VerfasserIn)
Weitere Verfasser: Campi-Azevedo, Ana Carolina, Speziali, Elaine, do Valle Antonelli, Lis Ribeiro, Peruhype-Magalhães, Vanessa, de Rezende, Izabela Maurício, Alves, Pedro Augusto, Pascoal-Xavier, Marcelo Antônio, Pereira, Leonardo Soares, Dutra, Maria Rita Teixeira, Ramalho, Dario Brock, Cenachi, Adriana, de Paula, Ludmila, Santos, Tayrine Araujo, do Carmo Said, Rodrigo Fabiano, Calzavara-Silva, Carlos Eduardo, Coelho-Dos-Reis, Jordana Grazziela Alves, de Magalhães, Clara Ramos, Rabelo, Lara Luíza Cerávolo, Valim, Valéria, Brito-de-Sousa, Joaquim Pedro, da Costa-Rocha, Ismael Artur, de Souza Gomes, Matheus, Amaral, Laurence Rodrigues, de Lima, Sheila Maria Barbosa, Trindade, Gisela Freitas, Santos, Renata Tourinho, da Silva, Juliana Fernandes Amorim, Monath, Thomas, LaBeaud, Angelle Desiree, Drumond, Betânia Paiva, Martins-Filho, Olindo Assis, Teixeira-Carvalho, Andréa, Yellow Fever Collaborative Group
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2023
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Chemokines Cytokines Late hepatitis Prognostic biomarkers Yellow fever Biomarkers Yellow Fever Vaccine